Lam Research funds expansion of critical care infrastructure at Hassan Institute of Medical Sciences (HIMS), Karnataka
“At Lam Research, we remain committed to giving back and creating a positive impact in our communities by investing in education, health improvement and environmental protection programs, among others,” said Rangesh Raghavan, Corporate Vice President and General Manager of Lam Research India. “Since the start of the COVID-19 pandemic, we have focused on supporting healthcare systems and helping frontline healthcare workers in their fight against the virus. The expansion of critical care infrastructure at HIMS is a step in the same direction.
HIMS faced a shortage of intensive care beds during the second wave of COVID-19 in India, reason why the Hassan district administration decided to add 40 intensive care beds to take care of the patients (Source). HIMS used Lam’s donation to obtain essential medical equipment such as pediatric ventilators, intensive care beds, multipara monitors, pulse oximeters, infusion pumps, syringe pumps, pediatric LED laryngoscopes, ventilation circuits, high-flow humidified nasal cannula circuits and nasal pins.
“We are grateful to Lam Research for assisting us in expanding our critical care facilities,” said Dr Ravikumar BC, director of Hassan Institute of Medical Sciences. “With the third wave of COVID-19 in India Expected to affect more children, increasing intensive care bed capacity will allow HIMS to treat additional patients while treating pediatric cases that may require critical care.
Lam Research India has also funded vaccination campaigns in various Bangalore-schools with which its corporate social responsibility organization engages. Nearly 900 adults have been vaccinated, including parents, siblings and immediate family members, as well as school staff. Since the start of the pandemic, the company has provided COVID-19 relief and support, including funding for 7,500 PPE kits at government hospitals in Karnataka to help frontline healthcare workers fight the virus.
In addition to contributing to the financing of additional intensive care beds, the $ 1 million for COVID-19 relief efforts in India announced in May 2021 helped support Direct Relief’s broader efforts by India.
About Lam Research
Lam Research Corporation is a global provider of innovative wafer fabrication equipment and services for the semiconductor industry. As a trusted and collaborative partner of the world’s leading semiconductor companies, we combine superior systems engineering capabilities, technology leadership, and an unwavering commitment to customer success to accelerate innovation through improved device performance. In fact, today almost all advanced chips are built with Lam technology. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company based in Fremont, Calif., With operations worldwide. Learn more at www.lamresearch.com. (LRCX-B)
SOURCE Lam Research Corporation